MXPA04001402A - Compuestos de imidazopiridina novedosos con efecto terapeutico. - Google Patents

Compuestos de imidazopiridina novedosos con efecto terapeutico.

Info

Publication number
MXPA04001402A
MXPA04001402A MXPA04001402A MXPA04001402A MXPA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A MX PA04001402 A MXPA04001402 A MX PA04001402A
Authority
MX
Mexico
Prior art keywords
therapeutic effect
imidazopyridine compounds
novel imidazopyridine
novel
compounds
Prior art date
Application number
MXPA04001402A
Other languages
English (en)
Spanish (es)
Inventor
Starke Ingemar
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA04001402A publication Critical patent/MXPA04001402A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MXPA04001402A 2001-08-22 2002-08-21 Compuestos de imidazopiridina novedosos con efecto terapeutico. MXPA04001402A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102808A SE0102808D0 (sv) 2001-08-22 2001-08-22 New compounds
PCT/SE2002/001489 WO2003018582A1 (en) 2001-08-22 2002-08-21 Novel imidazopyridine compounds with therapeutic effect

Publications (1)

Publication Number Publication Date
MXPA04001402A true MXPA04001402A (es) 2004-05-27

Family

ID=20285105

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001402A MXPA04001402A (es) 2001-08-22 2002-08-21 Compuestos de imidazopiridina novedosos con efecto terapeutico.

Country Status (19)

Country Link
US (1) US20040220209A1 (https=)
EP (1) EP1421083A1 (https=)
JP (1) JP2005501870A (https=)
KR (1) KR20040036723A (https=)
CN (1) CN100343252C (https=)
AR (1) AR035465A1 (https=)
BR (1) BR0211846A (https=)
CA (1) CA2456350A1 (https=)
HU (1) HUP0401350A3 (https=)
IL (1) IL160143A0 (https=)
IS (1) IS7159A (https=)
MX (1) MXPA04001402A (https=)
NO (1) NO20040760L (https=)
NZ (1) NZ531110A (https=)
PL (1) PL367971A1 (https=)
RU (1) RU2294935C2 (https=)
SE (1) SE0102808D0 (https=)
WO (1) WO2003018582A1 (https=)
ZA (1) ZA200401114B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301904D0 (sv) 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
EP1682133A1 (en) 2003-11-03 2006-07-26 AstraZeneca AB Imidazo 1,2-a pyridine derivatives for the treatment of silent gastro-esophageal reflux
US20080033006A1 (en) * 2004-01-26 2008-02-07 Altana Pharma Ag 1,2,4-Triazolo[ 1,5-A] Pyridines as Gastric Acid Secretion Inhibitors
US20090291977A1 (en) * 2004-12-17 2009-11-26 Madoka Jinno Chromane Derivatives Useful As Acid Pump Antagonists
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
JP2009530262A (ja) * 2006-03-17 2009-08-27 ラクオリア創薬株式会社 クロマン誘導体
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
KR200449743Y1 (ko) * 2008-03-11 2010-08-05 주식회사 보루네오가구 파티션용 상부 스크린의 고정구조
FI20086158A0 (fi) 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
EP2452680B1 (en) 2009-07-09 2019-12-18 RaQualia Pharma Inc. Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility
WO2011036127A1 (en) * 2009-09-24 2011-03-31 F. Hoffmann-La Roche Ag Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors
FR2962437B1 (fr) 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique
US9598409B2 (en) * 2013-01-31 2017-03-21 Neomed Institute Imidazopyridine compounds and uses thereof
JP2016520047A (ja) * 2013-04-30 2016-07-11 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ピラゾールアミドのPd触媒カップリング
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
AU2020228760A1 (en) 2019-02-25 2021-09-23 Glaxosmithkline Intellectual Property (No. 3) Limited Treatment with P2X3 modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
SK197A3 (en) * 1994-07-28 1997-06-04 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds

Also Published As

Publication number Publication date
US20040220209A1 (en) 2004-11-04
PL367971A1 (en) 2005-03-07
ZA200401114B (en) 2005-06-22
NO20040760L (no) 2004-02-20
IS7159A (is) 2004-02-20
AR035465A1 (es) 2004-05-26
JP2005501870A (ja) 2005-01-20
HUP0401350A3 (en) 2009-03-02
RU2004103628A (ru) 2005-06-27
CN1543464A (zh) 2004-11-03
HUP0401350A2 (hu) 2004-12-28
CA2456350A1 (en) 2003-03-06
BR0211846A (pt) 2004-09-08
NZ531110A (en) 2005-10-28
IL160143A0 (en) 2004-06-20
EP1421083A1 (en) 2004-05-26
RU2294935C2 (ru) 2007-03-10
SE0102808D0 (sv) 2001-08-22
CN100343252C (zh) 2007-10-17
KR20040036723A (ko) 2004-04-30
WO2003018582A1 (en) 2003-03-06

Similar Documents

Publication Publication Date Title
MY121389A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
SE9700661D0 (sv) New compounds
MXPA04001402A (es) Compuestos de imidazopiridina novedosos con efecto terapeutico.
SE9704404D0 (sv) New compounds
MX2011005769A (es) Derivados de imidazopiridina que inhiben la secrecion del acido gastrico.
SE9401197D0 (sv) Active compounds
SE9802794D0 (sv) New compounds
SE9602286D0 (sv) New compounds
MY121387A (en) Imidazo[1,2-a]pyridine derivatives for the treatment of gastrointestinal diseases
TW200508234A (en) Novel imidazopyridine compound I with therapeutic effect
ATE381568T1 (de) Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen
MY140718A (en) Novel imidazopyridine compound ii with therapeutic effect
TW200505866A (en) Novel imidazopyridine compound iii with therapeutic effect
TW261613B (https=)
AR044854A1 (es) Compuesto de imidazopiridina
MX9704136A (es) Compuestos para la inhibicion de la secrecion de acido gastrico.